Position in AUPH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,573,119
+$233,391 QoQ
Shares Held
92,700
+2.5% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#81
of 281 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OMERS ADMINISTRATION Corp holds $69,579,172 across 33 Biotechnology names. AUPH ranks #12 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
50,671 | $12,402,740 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,073 | $10,467,591 | |
| 3 | RPRX |
Royalty Pharma plc
|
133,435 | $7,481,700 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,099 | $6,297,130 | |
| 5 | INCY |
Incyte Corp
|
45,186 | $5,122,284 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
47,989 | $3,756,099 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
30,700 | $2,669,365 | |
| 8 | RIGL |
Rigel Pharmaceuticals Inc
|
51,900 | $2,030,328 |
All Filings in AUPH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,573,119 | 92,700 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,339,728 | 90,400 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $229,840 | 20,800 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||